(NDX1) Nordex SE - Overview
Sector: Industrials | Industry: Specialty Industrial Machinery | Exchange: XETRA (Germany) | Market Cap: 10.910m EUR | Total Return: 198.1% in 12m
Wind Turbines, Project Development, Maintenance, Spare Parts, Monitoring
Total Rating 67
Safety 67
Buy Signal 1.36
Specialty Industrial Machinery
Industry Rotation: +6.3
Industry Rotation: +6.3
Market Cap:
12.9B
Avg Turnover: 25.8M EUR
Avg Turnover: 25.8M EUR
ATR:
4.03%
Peers RS (IBD): 98.3
Peers RS (IBD): 98.3
Risk 5d forecast
Volatility40.3%
Rel. Tail Risk-6.34%
Reward TTM
Sharpe Ratio2.56
Alpha190.81
Character TTM
Beta0.117
Beta Downside-0.669
Drawdowns 3y
Max DD31.43%
CAGR/Max DD2.07
EPS (Earnings per Share)
EPS CAGR: 236.71%
EPS Trend: 92.0%
EPS Trend: 92.0%
Last SUE: 1.25
Qual. Beats: 1
Qual. Beats: 1
Revenue
Rev. CAGR: 30.60%
Rev. Trend: 65.1%
Rev. Trend: 65.1%
Last SUE: -0.02
Qual. Beats: 0
Qual. Beats: 0
Warnings
Altman Z'' 0.92 < 1.0 - financial distress zone
Tailwinds
Supp Ema20
Description: NDX1 Nordex SE
Nordex SE develops, manufactures, and distributes onshore wind turbines globally. The company operates in Projects and Services segments, offering turbine platforms such as Delta4000 and Delta series.
Its services include project development, maintenance, spare parts, remote monitoring, and upgrades for existing turbines. The wind energy sector is characterized by long project lead times and significant capital investment.
Nordex SE was founded in 1985 and is based in Hamburg, Germany. The business model relies on both initial turbine sales and recurring service revenue.
To deepen your understanding of Nordex SEs financial performance, further research on ValueRay could be beneficial.
- Global wind energy demand fuels turbine orders
- Raw material costs impact turbine manufacturing margins
- Government subsidies and renewable energy policies drive project viability
- Project execution delays affect revenue recognition
- Competition intensifies in the onshore wind turbine market
Piotroski VR‑10 (Strict)
4.5
| Net Income: 274.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 5.28 > 1.0 |
| NWC/Revenue: 5.22% < 20% (prev -0.09%; Δ 5.30% < -1%) |
| CFO/TA 0.12 > 3% & CFO 1.02b > Net Income 274.5m |
| Net Debt (-1.30b) to EBITDA (648.2m): -2.01 < 3 |
| Current Ratio: 1.09 > 1.5 & < 3 |
| Outstanding Shares: last quarter (236.5m) vs 12m ago 0.00% < -2% |
| Gross Margin: 19.97% > 18% (prev 0.15%; Δ 1.98k% > 0.5%) |
| Asset Turnover: 107.3% > 50% (prev 129.6%; Δ -22.28% > 0%) |
| Interest Coverage Ratio: 4.81 > 6 (EBITDA TTM 648.2m / Interest Expense TTM 97.1m) |
Altman Z''
0.92
| A: 0.05 (Total Current Assets 4.75b - Total Current Liabilities 4.36b) / Total Assets 8.44b |
| B: 0.03 (Retained Earnings 294.1m / Total Assets 8.44b) |
| C: 0.07 (EBIT TTM 467.0m / Avg Total Assets 7.04b) |
| D: 0.05 (Book Value of Equity 390.5m / Total Liabilities 7.16b) |
| Altman-Z'' Score: 0.92 = BB |
Beneish M
-2.63
| DSRI: 1.51 (Receivables 1.74b/1.11b, Revenue 7.55b/7.30b) |
| GMI: 0.76 (GM 19.97% / 15.18%) |
| AQI: 1.44 (AQ_t 0.38 / AQ_t-1 0.26) |
| SGI: 1.03 (Revenue 7.55b / 7.30b) |
| TATA: -0.09 (NI 274.5m - CFO 1.02b) / TA 8.44b) |
| Beneish M-Score: -2.63 (Cap -4..+1) = A |
What is the price of NDX1 shares?
As of April 17, 2026, the stock is trading at EUR 46.14 with a total of 922,849 shares traded.
Over the past week, the price has changed by +1.10%, over one month by +6.46%, over three months by +43.56% and over the past year by +198.06%.
Over the past week, the price has changed by +1.10%, over one month by +6.46%, over three months by +43.56% and over the past year by +198.06%.
Is NDX1 a buy, sell or hold?
Nordex SE has no consensus analysts rating.
What are the forecasts/targets for the NDX1 price?
| Analysts Target Price | - | - |
Nordex SE (NDX1) - Fundamental Data Overview
as of 17 April 2026
Market Cap USD = 12.88b (10.91b EUR * 1.1807 EUR.USD)P/E Trailing = 40.8319
P/E Forward = 39.8406
P/S = 1.4443
P/B = 8.5182
P/EG = 1.4987
Revenue TTM = 7.55b EUR
EBIT TTM = 467.0m EUR
EBITDA TTM = 648.2m EUR
Long Term Debt = 271.6m EUR (from longTermDebt, last quarter)
Short Term Debt = 78.1m EUR (from shortTermDebt, last quarter)
Debt = 628.0m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.30b EUR (from netDebt column, last quarter)
Enterprise Value = 9.61b EUR (10.91b + Debt 628.0m - CCE 1.93b)
Interest Coverage Ratio = 4.81 (Ebit TTM 467.0m / Interest Expense TTM 97.1m)
EV/FCF = 11.38x (Enterprise Value 9.61b / FCF TTM 844.1m)
FCF Yield = 8.79% (FCF TTM 844.1m / Enterprise Value 9.61b)
FCF Margin = 11.18% (FCF TTM 844.1m / Revenue TTM 7.55b)
Net Margin = 3.63% (Net Income TTM 274.5m / Revenue TTM 7.55b)
Gross Margin = 19.97% ((Revenue TTM 7.55b - Cost of Revenue TTM 6.05b) / Revenue TTM)
Gross Margin QoQ = 16.76% (prev 13.30%)
Tobins Q-Ratio = 1.14 (Enterprise Value 9.61b / Total Assets 8.44b)
Interest Expense / Debt = 3.52% (Interest Expense 22.1m / Debt 628.0m)
Taxrate = 24.33% (59.1m / 242.9m)
NOPAT = 353.4m (EBIT 467.0m * (1 - 24.33%))
Current Ratio = 1.09 (Total Current Assets 4.75b / Total Current Liabilities 4.36b)
Debt / Equity = 0.49 (Debt 628.0m / totalStockholderEquity, last quarter 1.28b)
Debt / EBITDA = -2.01 (Net Debt -1.30b / EBITDA 648.2m)
Debt / FCF = -1.54 (Net Debt -1.30b / FCF TTM 844.1m)
Total Stockholder Equity = 1.09b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.90% (Net Income 274.5m / Total Assets 8.44b)
RoE = 25.25% (Net Income TTM 274.5m / Total Stockholder Equity 1.09b)
RoCE = 34.37% (EBIT 467.0m / Capital Employed (Equity 1.09b + L.T.Debt 271.6m))
RoIC = 26.92% (NOPAT 353.4m / Invested Capital 1.31b)
WACC = 6.19% (E(10.91b)/V(11.54b) * Re(6.39%) + D(628.0m)/V(11.54b) * Rd(3.52%) * (1-Tc(0.24)))
Discount Rate = 6.39% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 81.65 | Cagr: 0.00%
[DCF] Terminal Value 86.40% ; FCFF base≈612.7m ; Y1≈666.3m ; Y5≈835.9m
[DCF] Fair Price = 103.4 (EV 23.16b - Net Debt -1.30b = Equity 24.46b / Shares 236.5m; r=6.19% [WACC]; 5y FCF grow 9.93% → 3.0% )
EPS Correlation: 91.96 | EPS CAGR: 236.7% | SUE: 1.25 | # QB: 1
Revenue Correlation: 65.13 | Revenue CAGR: 30.60% | SUE: -0.02 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.37 | Chg7d=+0.005 | Chg30d=-0.001 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=1.84 | Chg7d=+0.004 | Chg30d=+0.009 | Revisions Net=+3 | Growth EPS=+63.1% | Growth Revenue=+14.4%
EPS next Year (2027-12-31): EPS=2.15 | Chg7d=+0.016 | Chg30d=+0.075 | Revisions Net=+2 | Growth EPS=+16.9% | Growth Revenue=+9.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.5% (Discount Rate 7.9% - Earnings Yield 2.4%)
[Growth] Growth Spread = +10.6% (Analyst 16.1% - Implied 5.5%)